Genetic and antigenic characterization of a serotype P[6]G9 human rotavirus strain isolated in the United States.

During an epidemiologic survey of rotavirus infections established to monitor the prevalent G serotypes circulating in the United States, human P[6]G9, subgroup I rotavirus strains causing symptomatic infections were identified as the fourth most common serotype. In this report we describe the molecular and antigenic characterization of one of these P[6]G9 isolates (US1205). Neutralization and sequencing studies have demonstrated that both outer capsid proteins, VP7 and VP4, of US1205 are closely related to but genetically and antigenically distinguishable from those of standard G9 strains (e.g., F45, WI61) and standard P2A[6] strains (e. g., ST3, M37). Thus the complete antigenic type of US1205 is P2A[6]G9, subgroup I. Sequence analysis of the VP6 and NSP4 genes of US1205 indicates that strain US1205 possessed VP6 subgroup I and NSP4A genotype specificities. Finally, Northern hybridization studies suggest that the P[6]G9 strains are closely related to members of the DS-1 genogroup except for their P[6] VP4 gene, which has been commonly identified in strains of both major human genogroups, and their G9 VP7 gene, which may have been derived by reassortment with a Wa genogroup strain. Examination of historic collections and prospective surveillance of strains will be needed to determine whether this strain has been present for some time or if it is emerging to compete with the other common serotypes of rotavirus.

[1]  R. Glass,et al.  Rotavirus G and P types in children with acute diarrhea in Blantyre, Malawi, from 1997 to 1998: Predominance of novel P[6]G8 Strains , 1999, Journal of medical virology.

[2]  R. Glass,et al.  Detection and Characterization of Novel Rotavirus Strains in the United States , 1998, Journal of Clinical Microbiology.

[3]  R. Holman,et al.  Cost-effectiveness analysis of a rotavirus immunization program for the United States. , 1995, JAMA.

[4]  E. Palombo,et al.  Genetic characterization of the rotavirus nonstructural protein, NSP4. , 1997, Virology.

[5]  R. Glass,et al.  Sequence analysis of NSP4 gene of human rotavirus allows classification into two main genetic groups , 1997, Journal of medical virology.

[6]  V. Gouvea,et al.  A novel human rotavirus serotype with dual G5-G11 specificity. , 1997, The Journal of general virology.

[7]  R. Glass,et al.  Safety and Efficacy of High-dose Rhesus-Human Reassortant Rotavirus Vaccines-Report of the National Multicenter Trial , 1996, Pediatrics.

[8]  R. Glass,et al.  Unusual diversity of human rotavirus G and P genotypes in India , 1996, Journal of clinical microbiology.

[9]  E. Palombo,et al.  Genetic and antigenic characterization of a serotype G6 human rotavirus isolated in melbourne, Australia , 1995, Journal of medical virology.

[10]  R. Glass,et al.  Evaluation of Rhesus Rotavirus Monovalent and Tetravalent Reassortant Vaccines in US Children , 1995 .

[11]  H. Greenberg,et al.  Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. , 1995, Virology.

[12]  I. Shif Survey of rotavirus G and P types associated with human gastroenteritis in São Paulo, Brazil, from 1986 to 1992 , 1994, Journal of clinical microbiology.

[13]  E. Palombo,et al.  Sequences of VP6 genes of human rotavirus strain RV3 and its vaccine derivative. , 1994, The Journal of general virology.

[14]  R. Ward,et al.  Comparison of VP4 and VP7 of five murine rotavirus strains. , 1994, Virology.

[15]  M. Riepenhoff-talty,et al.  Comparative analysis of VP8* sequences from rotaviruses possessing M37-like VP4 recovered from children with and without diarrhoea. , 1994, The Journal of general virology.

[16]  P. Offit,et al.  VP4 genotyping of human rotavirus in the United States , 1994, Journal of clinical microbiology.

[17]  R. Glass,et al.  Characterization of the G serotype and genogroup of New Delhi newborn rotavirus strain 116E. , 1993, Virology.

[18]  B. Coulson,et al.  Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses. , 1993, Virology.

[19]  H. Greenberg,et al.  Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies , 1993, Journal of clinical microbiology.

[20]  K. Taniguchi,et al.  Antigenic and genetic analyses of human rotaviruses in Chiang Mai, Thailand: evidence for a close relationship between human and animal rotaviruses. , 1992, The Journal of infectious diseases.

[21]  R. Glass,et al.  Identification of group A rotavirus gene 4 types by polymerase chain reaction , 1992, Journal of clinical microbiology.

[22]  M. Estes,et al.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope , 1992, Journal of virology.

[23]  N. Kobayashi,et al.  Identification of operationally overlapping and independent cross-reactive neutralization regions on human rotavirus VP4. , 1990, The Journal of general virology.

[24]  R. Glass,et al.  Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens , 1990, Journal of clinical microbiology.

[25]  O. Nakagomi,et al.  Relative frequency of rotavirus serotypes in Yamagata, Japan, over four consecutive rotavirus seasons. , 1990, Research in Virology.

[26]  M. Estes,et al.  Rotavirus gene structure and function. , 1989, Microbiological reviews.

[27]  O. Nakagomi,et al.  Identification of rotavirus genogroups by RNA-RNA hybridization. , 1989, Molecular and cellular probes.

[28]  K. Green,et al.  Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes. , 1989, Virology.

[29]  O. Nakagomi,et al.  Occurrence of changes in human rotavirus serotypes with concurrent changes in genomic RNA electropherotypes , 1988, Journal of clinical microbiology.

[30]  R. Chanock,et al.  Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections , 1988, Journal of virology.

[31]  R. Chanock,et al.  Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus , 1988, Journal of virology.

[32]  R. Chanock,et al.  Cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus: nucleotide sequence analysis of antigenic mutants selected with monoclonal antibodies , 1988, Journal of virology.

[33]  P. Offit,et al.  Rotavirus isolate WI61 representing a presumptive new human serotype , 1987, Journal of clinical microbiology.

[34]  R. Cotton,et al.  Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates , 1985, Journal of virology.

[35]  H. Greenberg,et al.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. , 1984, The Journal of infectious diseases.

[36]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[37]  R. Chanock,et al.  Definition of human rotavirus serotypes by plaque reduction assay , 1982, Infection and immunity.